General Information of Drug (ID: DM95T5Z)

Drug Name
Sapablursen
Indication
Disease Entry ICD 11 Status REF
Polycythemia vera 2A20.4 Phase 2 [1]
Drug Type
Ligand-conjugated antisense
Cross-matching ID
TTD ID
D9VR6X

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TMPRSS6 messenger RNA (TMPRSS6 mRNA) TTNIUKC TMPS6_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05143957) A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients With Phlebotomy Dependent Polycythemia Vera (PD-PV). U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Ionis